ORKA — ORUKA THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ORUKA THERAPEUTICS INC (ORKA)
ORUKA THERAPEUTICS INC (ORKA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $131M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ORKA
How many top investors track ORKA
A small number of top investors own this.
ORKA Ownership Composition
How ORUKA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Other90.9%
- Hedge Funds9.1%
Tracked investors reporting ORKA
- Andreas HalvorsenMar 31, 2026Viking Global InvestorsShares2.7MValue$130.8M% Portfolio0.37%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1MValue$50M% Portfolio0.01%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares600KValue$18.2M% Portfolio0.02%
- Izzy EnglanderDec 31, 2025Millennium ManagementShares58.7KValue$1.8M% Portfolio0.00%
Recent activity
- $80.8MFeb 17, 2026
- $130.8MMay 15, 2026
Frequently asked questions
- How many institutional investors hold ORKA?
- 4 tracked institutional investors disclosed a position in ORKA (ORUKA THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ORKA?
- Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in ORKA, valued at $131M.
- Did institutional ownership of ORKA increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited ORKA.
- Where does this ORKA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.